US 11649251
Substituted inhibitors of menin-MLL and methods of use
granted A61KA61K31/5355A61K45/06
Quick answer
US patent 11649251 (Substituted inhibitors of menin-MLL and methods of use) held by Kura Oncology, Inc. expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Kura Oncology, Inc.
- Grant date
- Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/5355, A61K45/06, A61K9/0019, A61K9/0053